Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial).

@article{Kodali2011EarlyAL,
  title={Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial).},
  author={Susheel K. Kodali and William W O'neill and Jeffrey W. Moses and Mathew Russell Williams and Craig R Smith and Murat E Tuzcu and Lars Georg Svensson and Samir Kapadia and George S. Hanzel and Ajay J. Kirtane and Martin B. Leon},
  journal={The American journal of cardiology},
  year={2011},
  volume={107 7},
  pages={1058-64}
}
Transcatheter aortic valve implantation (TAVI) with the Cribier-Edwards prosthesis may provide an alternative to conventional aortic valve replacement in high-risk patients with aortic stenosis. Previous studies have indicated that TAVI is feasible in this patient population. Transcatheter implantation of a Cribier-Edwards prosthesis was attempted in 55 patients in a United States Food and Drug Administration-approved prospective observational study. Clinical and echocardiographic outcomes were… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 34 extracted citations

Functional Status and Quality of Life After Transcatheter Aortic Valve Replacement

Annals of Internal Medicine • 2014
View 6 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…